Agilent Effect of Silica-Support Type Reversed-Phase Separation of Tricyclic Antidepressants Application Note

This document describes the use of highly purified, less-acidic Type-B silica support (ZORBAX Rx-SIL) in reversed-phase separation of tricyclic antidepressants, which resulted in improved band shape and column efficiency for these basic drugs. Reduced retention for column with Type-B silica is due to lower surface area of its support.


Agilent Effect of Silica-Support Type Reversed-Phase Separation of Tricyclic Antidepressants Application Note - cover page
Brand
Agilent
Document type
Product Leaflet
Language
English
Pages
2
File format
PDF
File size
953 KB
Published
03 July, 2012
Updated
30 September, 2023
MD5 checksum
D71C746F398C0FF7B8942980D40B9200

About this manual

This application note investigates the impact of different silica support types on the chromatographic separation of four tricyclic antidepressant drugs: Doxepin, Desipramine, Amitriptyline, and Trimipramine. The study compares a standard Type A silica (ZORBAX ODS) with a highly purified, less-acidic Type B silica (ZORBAX Rx-SIL).

What's inside

  • Application
  • Highlights
  • Effect of Silica-Support Type

Frequently asked questions

What are the specific amounts of each tricyclic antidepressant used in the separation test?

The test used 0.125 yg of Doxepin, 0.25 yg of Desipramine, 0.25 yg of Amitriptyline, and 0.25 yg of Trimipramine.

What is the flow rate for the mobile phase in this separation procedure?

The procedure specifies a flow rate of 1.0 mL/min.

Download PDF (953 KB)

More Agilent Manuals


View all Agilent manuals →